Table 2.
Substrate | Enzyme | k s (h−1) | KL (g/L) | k i (×10−2 h−1) | t1/2 (h) | t1/2 95% CI (h) |
---|---|---|---|---|---|---|
DACS | Cb broth | 54a | 1.1 | 4.4 | 16 | 13–18 |
DACS | CTec2 | 23 ± 3 | 100a | 0.3 | 206 | 54- |
APCS | Cb broth | 55 ± 7 | 100a | 2.2b | 31 | — |
APCS | CTec2 | 59 ± 54 | 100a | 3.0 | 23 | 7–142 |
CFCS | Cb broth | 54 ± 2 | 100a | 2.2b | 31 | — |
CFCS | CTec2 | 20 ± 2 | 100a | 0 | n/a | 169- |
Avicel | Cb broth | 47 ± 4 | 100a | 2.2b | 31 | — |
Avicel | CTec2 | 6 ± 1 | 100a | 1.1 | 65 | 49–92 |
The model was fit to each progress curve shown in Fig. S3 by varying k i and k s or KL. Values shown are best fit values and either their associated standard deviations or 95% confidence intervals.
aValue was fixed while estimating values for remaining parameters.
bValue was estimated using a global fit to CelA data on CFCS, APCS and Avicel.